Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,271.20
-17.70 (-1.37%)
Oct 31, 2025, 3:30 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 322.51 billion as of October 31, 2025. Its market cap has decreased by -24.43% in one year.
Market Cap
322.51B
Enterprise Value
339.48B
Revenue
91.57B
Ranking
n/a
PE Ratio
41.43
Stock Price
1,271.20
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 322.51B, an increase of 9,919.69%. That is a compound annual growth rate of 21.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 322.51B | -25.01% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | 277.65B | 93.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.79T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.10T |
| Mankind Pharma | 984.02B |
| Zydus Lifesciences | 980.52B |
| Fortis Healthcare | 772.36B |
| Aurobindo Pharma | 661.47B |